|
|
regulation of defense response
|
GO:0031347 |
233 |
0.980
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.967
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.958
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.924
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.860
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.845
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.814
|
Human |
|
|
hemostasis
|
GO:0007599 |
78 |
0.783
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.755
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.755
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.752
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.745
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.698
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.687
|
Human |
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.683
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.675
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.675
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.674
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.662
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.636
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.636
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.571
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.568
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.542
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.531
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.530
|
Human |
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.526
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.510
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.508
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.500
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.492
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.492
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.489
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.463
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.448
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.428
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.421
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.421
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.418
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.415
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.410
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.401
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.399
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.392
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.380
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.376
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.366
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.365
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.336
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.327
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.326
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.323
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.321
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.297
|
Human |
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.296
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.288
|
|
|
|
positive regulation of type ii hypersensitivity
|
GO:0002894 |
4 |
0.288
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.286
|
|
|
|
regulation of inflammatory response to antigenic stimulus
|
GO:0002861 |
21 |
0.276
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.271
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.271
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.268
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.267
|
|
|
|
positive regulation of sterol transport
|
GO:0032373 |
9 |
0.267
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.255
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.252
|
|
|
|
regulation of type ii hypersensitivity
|
GO:0002892 |
4 |
0.247
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.240
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.238
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.235
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.234
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.234
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.233
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.232
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.231
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.230
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.227
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.221
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.219
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.218
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.207
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.206
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.206
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.204
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.202
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.195
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.194
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.193
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.191
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.190
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.189
|
Human |
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.188
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.187
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.185
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.182
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.178
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.175
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.173
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.173
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.172
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.170
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.169
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.169
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.168
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.168
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.167
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.165
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.164
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.164
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.159
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.153
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.152
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.150
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.150
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.149
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.147
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.147
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.146
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.146
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.146
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.142
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.141
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.138
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.138
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.137
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.136
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.136
|
Human |
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.133
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.131
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.130
|
Human |
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.129
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.129
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.125
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.124
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.123
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.122
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.121
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.120
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
26 |
0.120
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.119
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.118
|
|
|
|
positive regulation of type iia hypersensitivity
|
GO:0001798 |
4 |
0.115
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.115
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.113
|
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.112
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.112
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.111
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.111
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.111
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.110
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.108
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.107
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.107
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.106
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.106
|
|
|
|
positive regulation of cytokine production involved in immune response
|
GO:0002720 |
19 |
0.106
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.105
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.105
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.105
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.104
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.104
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.103
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.102
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.102
|
|
|
|
positive regulation of type iii hypersensitivity
|
GO:0001805 |
3 |
0.102
|
|
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
0.102
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.101
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.100
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.100
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.099
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.099
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.099
|
|
|
|
positive regulation of immunoglobulin mediated immune response
|
GO:0002891 |
26 |
0.098
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.096
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.096
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.095
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.094
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.094
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.094
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.093
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.092
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.092
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.092
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.090
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.090
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.090
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.090
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.089
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.089
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.088
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.088
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.088
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.087
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.087
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.087
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.086
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.086
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.085
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.083
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.083
|
|
|
|
positive regulation of cholesterol transport
|
GO:0032376 |
9 |
0.083
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.082
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.081
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.081
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.081
|
|
|
|
positive regulation of beta amyloid formation
|
GO:1902004 |
4 |
0.081
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.080
|
Human |
|
|
regulation of neutrophil chemotaxis
|
GO:0090022 |
14 |
0.080
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.080
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.079
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.079
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.079
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.079
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.079
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.078
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.078
|
|
|
|
negative regulation of cellular amide metabolic process
|
GO:0034249 |
4 |
0.078
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.078
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.078
|
|
|
|
positive regulation of presynaptic membrane organization
|
GO:1901631 |
1 |
0.078
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.077
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.077
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.076
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.076
|
Human |
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.076
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.076
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.074
|
Mouse |
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.074
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.074
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.073
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.073
|
|
|
|
positive regulation of acute inflammatory response
|
GO:0002675 |
16 |
0.072
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.072
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.072
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.072
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.071
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.070
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.070
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.070
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.070
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.070
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.069
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.069
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.069
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.069
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.069
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.069
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.068
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.068
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.068
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.068
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.068
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.067
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.067
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.067
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.066
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.066
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.066
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.066
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.065
|
|
|
|
positive regulation by symbiont of defense related host nitric oxide production
|
GO:0052347 |
1 |
0.064
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.064
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
25 |
0.063
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.063
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.063
|
|
|
|
tumor necrosis factor biosynthetic process
|
GO:0042533 |
10 |
0.062
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.062
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.062
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.061
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.061
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.060
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.060
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.060
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.059
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.059
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.059
|
Mouse |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.059
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.058
|
|
|
|
urea cycle
|
GO:0000050 |
2 |
0.058
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.058
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.058
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.057
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.057
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.057
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.057
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.057
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.057
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.056
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.056
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.056
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.055
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.055
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.055
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.055
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.055
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class i
|
GO:0002474 |
9 |
0.055
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.055
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.055
|
Mouse |
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.055
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.054
|
|
|
|
positive regulation of toll like receptor 4 signaling pathway
|
GO:0034145 |
1 |
0.054
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.054
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.054
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.054
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.054
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.052
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.052
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.052
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.052
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.052
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.051
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.051
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.051
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.051
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.050
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.050
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.050
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.050
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.050
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.050
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.050
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.050
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.049
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.049
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.049
|
|
|
|
positive regulation of hypersensitivity
|
GO:0002885 |
7 |
0.049
|
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.049
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.049
|
|
|
|
positive regulation of amyloid precursor protein catabolic process
|
GO:1902993 |
4 |
0.048
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.048
|
|
|
|
positive regulation of interleukin 12 production
|
GO:0032735 |
21 |
0.048
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.048
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.047
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.047
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.047
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.047
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.047
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.047
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.047
|
|
|
|
toll like receptor 4 signaling pathway
|
GO:0034142 |
9 |
0.046
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.046
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.046
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.046
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.045
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.045
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.045
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
30 |
0.045
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.045
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.044
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.044
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.044
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.044
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.043
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.043
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.043
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.043
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.043
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.043
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.043
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.042
|
Human |
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.042
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.042
|
Mouse |
|
|
response to low density lipoprotein particle
|
GO:0055098 |
2 |
0.042
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.042
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.042
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.042
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.042
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.042
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.042
|
Mouse |
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.042
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.041
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.041
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.041
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.041
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.041
|
|
|
|
regulation of type iii hypersensitivity
|
GO:0001803 |
3 |
0.041
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.041
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.041
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.041
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.041
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.041
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.041
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.041
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.041
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.040
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.040
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.040
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.040
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.040
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.040
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.040
|
|
|
|
response to bacterial lipoprotein
|
GO:0032493 |
4 |
0.040
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.040
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.039
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.039
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.039
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.039
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.039
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.039
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.039
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.038
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.038
|
|
|
|
positive regulation of acute inflammatory response to antigenic stimulus
|
GO:0002866 |
7 |
0.038
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.038
|
|
|
|
regulation of alpha beta t cell proliferation
|
GO:0046640 |
18 |
0.038
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.038
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.038
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.038
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.038
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.038
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.037
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.037
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.037
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.037
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.037
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.037
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.037
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.037
|
Mouse |
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.037
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.037
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.037
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.037
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.036
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.036
|
Mouse |
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.036
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.036
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.036
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.036
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.036
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.035
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.035
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.035
|
|
|
|
regulation of inclusion body assembly
|
GO:0090083 |
1 |
0.035
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.035
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.035
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.035
|
|
|
|
induction by organism of immune response of other organism involved in symbiotic interaction
|
GO:0052558 |
1 |
0.035
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.035
|
|
|
|
negative regulation of interferon gamma mediated signaling pathway
|
GO:0060336 |
1 |
0.035
|
|
|
|
positive regulation of myeloid leukocyte cytokine production involved in immune response
|
GO:0061081 |
9 |
0.034
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.034
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.034
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.034
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.034
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.034
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.034
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.034
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.034
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.034
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.034
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.034
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.033
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.033
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.033
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.033
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.033
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.033
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.033
|
|
|
|
interleukin 12 production
|
GO:0032615 |
32 |
0.033
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.033
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
0 |
0.033
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.033
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.032
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.032
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.032
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.032
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.032
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.032
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.032
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.032
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.032
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.032
|
|
|
|
metanephric glomerular visceral epithelial cell differentiation
|
GO:0072248 |
2 |
0.032
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.032
|
|